These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4100034)

  • 21. D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.
    Kauschansky A; Frydman M; Assa S; Kwon OJ; Israel S; Lazard D; Sprecher E; Bloch K; Brautbar C; Vardi P
    Clin Immunol Immunopathol; 1998 Dec; 89(3):279-83. PubMed ID: 9837698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolism and pharmacology of D-penicillamine in man.
    Perrett D
    J Rheumatol Suppl; 1981; 7():41-50. PubMed ID: 7014876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic reactions to penicillamine in patients with Wilson's disease.
    Walshe JM
    Postgrad Med J; 1968 Oct; ():Suppl:6-8. PubMed ID: 5706614
    [No Abstract]   [Full Text] [Related]  

  • 24. [Penicillamine-induced pemphigus].
    Kind P; Goerz G; Gleichmann E; Plewig G
    Hautarzt; 1987 Sep; 38(9):548-52. PubMed ID: 3319968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.
    Chan CY; Baker AL
    Am J Gastroenterol; 1994 Mar; 89(3):442-3. PubMed ID: 8122662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

  • 27. Wilson's disease: initial worsening of neurologic syndrome with penicillamine therapy.
    Kher A; Bharucha BA; Kumta NB
    Indian Pediatr; 1992 Jul; 29(7):927-9. PubMed ID: 1428152
    [No Abstract]   [Full Text] [Related]  

  • 28. D-penicillamine-induced lupus erythematosus as an adverse reaction of treatment of Wilson's Disease.
    Antos AJ; Litwin T; Przybyłkowski A; Skowrońska M; Kurkowska-Jastrzębska I; Członkowska A
    Neurol Neurochir Pol; 2021; 55(6):595-597. PubMed ID: 34704604
    [No Abstract]   [Full Text] [Related]  

  • 29. Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.
    Harders H; Cohnen E
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):10-2. PubMed ID: 122652
    [No Abstract]   [Full Text] [Related]  

  • 30. Penicillamine-induced dermal fragility in Wilson's disease (hepato-lenticular degeneration).
    Shaw M; Jarrett A
    Clin Exp Dermatol; 1981 Jul; 6(4):429-33. PubMed ID: 6458426
    [No Abstract]   [Full Text] [Related]  

  • 31. D-penicillamine-induced IgA deficiency in Wilson's disease.
    Proesmans W; Jaeken J; Eeckels R
    Lancet; 1976 Oct; 2(7989):804-5. PubMed ID: 61477
    [No Abstract]   [Full Text] [Related]  

  • 32. Penicillamine-induced arthropathy in Wilson's disease.
    Walshe JM; Golding DN
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):4-6. PubMed ID: 122670
    [No Abstract]   [Full Text] [Related]  

  • 33. D-penicillamine induced Goodpasture's syndrome in Wilson's disease.
    Sternlieb I; Bennett B; Scheinberg IH
    Ann Intern Med; 1975 May; 82(5):673-6. PubMed ID: 1094875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.
    Svetel M; Sternić N; Pejović S; Kostić VS
    Mov Disord; 2001 May; 16(3):568-9. PubMed ID: 11391761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
    Ritland S
    Tidsskr Nor Laegeforen; 1987 Aug; 107(22):1770-1. PubMed ID: 3660361
    [No Abstract]   [Full Text] [Related]  

  • 36. [2 cases of verruciform perforating elastoma after prolonged administration of D-penicillamine in Wilson's disease].
    Sfar Z; Lakhoua H; Hafsia M; Amor RB; Mahfoudh H; Hamza B; Abdallah CB
    Tunis Med; 1977; 55(3):167-8. PubMed ID: 919044
    [No Abstract]   [Full Text] [Related]  

  • 37. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
    Hampel R; Meng W; Kallwellis G
    Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.
    Jaffe IA
    Springer Semin Immunopathol; 1981; 4(2):193-207. PubMed ID: 7034252
    [No Abstract]   [Full Text] [Related]  

  • 39. [Renal accidents in 2 cases of Wilson's disease treated with penicillamine].
    Boudin G; Pépin B
    Bull Mem Soc Med Hop Paris; 1965 Apr; 116(8):833-42. PubMed ID: 5834267
    [No Abstract]   [Full Text] [Related]  

  • 40. Nephrotic syndrome in the course of treatment of Wilson's disease with DL-penicillamine.
    Karp M; Lurie M; Yonis Z
    Arch Dis Child; 1966 Dec; 41(220):684-7. PubMed ID: 5927925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.